Search IPOs
ACCRETION · BSE · Healthcare
Accretion Nutraveda IPO listed on 04 Feb 2026 on BSE at ₹191.00, a gain of 48.06% over the issue price of ₹129.00. The IPO was subscribed 1.83x overall.
Accretion Nutraveda IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 28 Jan 2026 |
| IPO Close Date | 30 Jan 2026 |
| Basis of Allotment | 02 Feb 2026 |
| Initiation of Refunds | 03 Feb 2026 |
| Credit of Shares to Demat | 03 Feb 2026 |
| Listing Date | 04 Feb 2026 |
Listing day gain
+48.06%
Listed at ₹191 (issue ₹129)
Issue
₹129
Listing
₹191
Current
₹191.2
+48.22% vs issue
Day range
₹190.5 – ₹200.55
Issue Size
1,920,000 shares
(aggregating up to ₹25.00 Cr)
Issue Price
₹122 – ₹129
Face Value
₹10/share
Market Lot
1,000 shares
Retail Min Investment
₹258,000
Listing At
BSE
Sale Type
fresh issue
Fresh Issue
1,824,000 shares
(aggregating up to ₹24 Cr)
Offer for Sale
[.]
Reserved for Market Maker
96,000 shares
(aggregating up to ₹1.24 Cr)
Issue Type
book building
Open Date
28 Jan
Close Date
30 Jan
Allotment
02 Feb
Listing
04 Feb
Last updated: 8 months ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 04 Feb 2026 Latest | ₹129 | ₹68 | ₹197 | ₹68 |
52.71%
|
12:07 PM |
| 03 Feb 2026 | ₹129 | ₹68 | ₹197 | ₹68 |
52.71%
|
2:45 PM |
Showing the 2 most recent GMP entries.
View full GMP historyLatest snapshot: 30 Jan 2026
| Category | Subscribed (x) | No. of Applications |
|---|---|---|
| QIB | 1.01x | - |
| NII | 2.08x | - |
| bNII (bids above ₹10L) | 1.95x | - |
| sNII (bids below ₹10L) | 2.33x | - |
| Retail Investors | 2.19x | - |
| Total | 1.83x | - |
Showing the latest subscription snapshot.
View full subscription historyMr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr. Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod & Mr. Vivek Ashok Kumar Patel are the company promoters.
New to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | ₹258,000 |
| Retail (Max) | 2 | 2,000 | ₹258,000 |
| S-HNI (Min) | 3 | 3,000 | ₹387,000 |
| S-HNI (Max) | 7 | 7,000 | ₹903,000 |
| B-HNI (Min) | 8 | 8,000 | ₹1,032,000 |
Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 908,000 (47.29%) |
|
•
Anchor Investor Shares Offered
|
546,000 (28.44%) |
|
•
QIB (Ex. Anchor) Shares Offered
|
362,000 (18.85%) |
| NII (HNI) Shares Offered | 276,000 (14.37%) |
|
•
bNII > ₹10L
|
184,000 (9.58%) |
|
•
sNII < ₹10L
|
92,000 (4.79%) |
| Retail Shares Offered | 640,000 (33.33%) |
| Market Maker Shares Offered | 96,000 (5.00%) |
| Total Shares Offered | 1,920,000 (99.99%) |
Accretion Nutraveda Limited is an Ahmedabad-based healthcare-focused CDMO. The company specializes in the manufacturing of a diverse range of Ayurvedic and nutraceutical products including tablets, capsules, oral liquids, oral powders, external preparations, and oils. Its portfolio covers various healthcare segments such as bone and joint care, respiratory care, cardiac care, skin and hair care, and baby care.
Key Strengths:
Growth:
Standalone · ₹ in Crores
| Particulars | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Total Revenue | 3.07 | 5.2 | 16.06 |
| Profit After Tax (PAT) | 0.28 | 0.82 | 2.61 |
| EBITDA | 0.59 | 1.21 | 3.65 |
| Total Assets | 4.06 | 4.64 | 10.86 |
| Net Worth | 0.26 | 1.08 | 5.35 |
| Reserves & Surplus | -0.1 | 0.72 | 4.86 |
| Total Borrowing | 1.97 | 2.17 | 3.86 |
Revenue & Profit Trend
The basis of allotment for Accretion Nutraveda IPO was finalised on 02 Feb 2026. You can check your allotment status using your PAN number or application number on the KFin Technologies Limited portal or BSE.
The Accretion Nutraveda IPO is expected to open in Jan 2026, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Accretion Nutraveda IPO is ₹122.00 - ₹129.00 per share.
As per market sources, Accretion Nutraveda IPO GMP is currently ₹68.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Accretion Nutraveda IPO stands at 1.83x overall.
The listing date for Accretion Nutraveda IPO is 04 Feb 2026.
No comments yet. Be the first to comment!
